Health X Platform Limited Promoter Increases Stake Through Market Purchase of 5,000 Shares

1 min read     Updated on 01 Apr 2026, 05:54 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Health X Platform Limited disclosed that promoter Mr. Banwari Lal Mittal acquired 5,000 equity shares worth Rs. 13,76,899.75 through market purchase on March 30, 2026. This increased his shareholding from 33.91% to 33.92%, with the transaction properly disclosed under SEBI insider trading regulations to BSE and NSE.

powered bylight_fuzz_icon
36591867

*this image is generated using AI for illustrative purposes only.

Sastasundar ventures has announced that its promoter Mr. Banwari Lal Mittal has acquired additional equity shares in the company through market purchase. The transaction was disclosed under Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015, with the company informing both BSE and NSE on April 1, 2026.

Share Acquisition Details

The promoter acquired 5,000 equity shares on March 30, 2026, through market purchase. The transaction details are presented below:

Parameter: Details
Number of Shares Acquired: 5,000 equity shares
Transaction Value: Rs. 13,76,899.75 (inclusive of taxes)
Transaction Date: March 30, 2026
Mode of Acquisition: Market Purchase
Intimation Date: March 31, 2026

Shareholding Pattern Changes

Following this acquisition, Mr. Banwari Lal Mittal's shareholding in Health X Platform Limited has increased marginally:

Shareholding Status: Before Transaction After Transaction
Number of Shares: 1,07,86,355 1,07,91,355
Percentage Holding: 33.91% 33.92%
Security Type: Equity Shares Equity Shares

Promoter Information

Mr. Banwari Lal Mittal, identified as a promoter of the company, holds PAN ADMPM0065G and DIN 00365809. His registered address is 1 Ashoka Road, 7th Floor, Flat No. 7A, Kolkata - 700027. The disclosure confirms no trading in derivatives during this period.

Regulatory Compliance

The company has fulfilled its disclosure obligations under SEBI regulations by filing Form C with the designated stock exchanges. Health X Platform Limited trades on BSE with stock code 533259 and on NSE with symbol SASTASUNDR. The disclosure was signed by Company Secretary & Compliance Officer Pratap Singh and communicated to both exchanges as required under insider trading regulations.

Historical Stock Returns for Sastasundar Ventures

1 Day5 Days1 Month6 Months1 Year5 Years
+5.08%-2.56%-4.68%-11.49%+6.73%+136.95%

Will this promoter acquisition signal a potential delisting attempt or further consolidation of ownership in Sastasundar Ventures?

How might this increased promoter confidence impact the company's upcoming strategic initiatives or expansion plans?

Could this market purchase indicate insider expectations of positive developments or improved financial performance ahead?

Health X Platform Promoter Group Increases Stake to 74.84% Through Market Purchases

2 min read     Updated on 28 Mar 2026, 11:13 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Health X Platform Limited disclosed promoter group acquisitions totaling 1,90,355 shares through market purchases between November 2025 and March 2026. The promoter group's collective shareholding increased from 74.24% to 74.84%, with Banwari Lal Mittal acquiring 1,70,355 shares to reach 33.91% individual holding and Luv Kush Projects Limited adding 20,000 shares to achieve 11.96% stake.

powered bylight_fuzz_icon
35814436

*this image is generated using AI for illustrative purposes only.

Health X Platform Limited (formerly Sastasundar Ventures Limited) has disclosed substantial share acquisitions by its promoter group under SEBI Takeover Regulations. The comprehensive acquisition involved multiple transactions between November 2025 and March 2026, demonstrating sustained confidence in the company's prospects.

Promoter Group Acquisition Details

The promoter group, led by Banwari Lal Mittal, acquired a total of 1,90,355 equity shares through market purchases. The acquisition period spanned from November 17, 2025, to March 24, 2026, with transactions conducted on the open market.

Parameter: Details
Total Shares Acquired: 1,90,355 equity shares
Acquisition Period: November 17, 2025 to March 24, 2026
Transaction Mode: Market Purchase
Percentage Increase: 0.5984%
Stock Exchanges: BSE (533259) and NSE (SASTASUNDR)

Updated Promoter Group Shareholding Pattern

The acquisitions resulted in a significant increase in the promoter group's collective shareholding. The group's total holding now represents nearly three-quarters of the company's equity capital.

Shareholding Status: Before Acquisition After Acquisition Change
Total Promoter Shares: 2,36,15,272 2,38,05,627 +1,90,355
Percentage Holding: 74.24% 74.84% +0.60%
Equity Share Capital: 3,18,10,500 shares 3,18,10,500 shares No change

Individual Promoter Holdings

Banwari Lal Mittal emerged as the primary acquirer within the promoter group, significantly increasing his individual stake. Luv Kush Projects Limited also participated in the acquisition drive.

Promoter Name: Shares Acquired New Holding New Percentage
Banwari Lal Mittal: 1,70,355 1,07,86,355 33.91%
Luv Kush Projects Limited: 20,000 38,05,234 11.96%
Other Promoters: No change - -

Regulatory Compliance and Disclosure

Health X Platform Limited fulfilled its regulatory obligations by submitting the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The disclosure was communicated to both BSE and NSE on March 27, 2026.

Key compliance highlights include:

  • Comprehensive promoter group details provided
  • Timely disclosure within prescribed timeframes
  • Proper documentation with acquirer signatures
  • Communication to designated stock exchanges
  • Complete shareholding pattern transparency

The company operates under ISIN INE019J01013 and maintains listings on both major Indian stock exchanges. The continued acquisitions reflect the promoter group's sustained investment confidence and strategic commitment to the company's growth trajectory.

Historical Stock Returns for Sastasundar Ventures

1 Day5 Days1 Month6 Months1 Year5 Years
+5.08%-2.56%-4.68%-11.49%+6.73%+136.95%

What strategic initiatives or expansion plans might Health X Platform be pursuing that prompted such sustained promoter confidence over this 4-month acquisition period?

How might the increased promoter concentration at 74.84% affect minority shareholder interests and the company's ability to raise external capital for future growth?

Could this significant promoter stake increase signal preparation for a potential delisting or privatization of Health X Platform?

More News on Sastasundar Ventures

1 Year Returns:+6.73%